Oncolytics Biotech Inc (ONC) — Cash Flow-to-Debt Ratio
Oncolytics Biotech Inc (ONC) has a Cash Flow-to-Debt Ratio of -0.39x as of June 2025, meaning its operating cash flow of CA$-5.47 Million could theoretically repay 0% of its total liabilities (CA$13.88 Million) in one year. Check how aggressively does Oncolytics Biotech Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oncolytics Biotech Inc Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Oncolytics Biotech Inc across 26 annual periods. Also explore ONC total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Oncolytics Biotech Inc (1999–2024)
Year-by-year debt coverage analysis for Oncolytics Biotech Inc. For market capitalisation and broader financial context, see ONC market cap.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.90x | CA$-26.97 Million | CA$14.20 Million | ▲ +24.9% |
| 2023 | -2.53x | CA$-28.45 Million | CA$11.26 Million | ▼ -17.2% |
| 2022 | -2.16x | CA$-23.36 Million | CA$10.83 Million | ▲ +6.0% |
| 2021 | -2.29x | CA$-22.43 Million | CA$9.78 Million | ▲ +0.3% |
| 2020 | -2.30x | CA$-22.07 Million | CA$9.59 Million | ▼ -128.4% |
| 2019 | -1.01x | CA$-19.91 Million | CA$19.77 Million | ▲ +26.8% |
| 2018 | -1.37x | CA$-11.92 Million | CA$8.67 Million | ▲ +8.9% |
| 2017 | -1.51x | CA$-14.89 Million | CA$9.87 Million | ▲ +50.8% |
| 2016 | -3.07x | CA$-12.48 Million | CA$4.07 Million | ▲ +44.7% |
| 2015 | -5.55x | CA$-15.03 Million | CA$2.71 Million | ▲ +4.9% |
| 2014 | -5.83x | CA$-19.68 Million | CA$3.37 Million | ▼ -43.4% |
| 2013 | -4.07x | CA$-24.44 Million | CA$6.01 Million | ▲ +13.4% |
| 2012 | -4.70x | CA$-34.26 Million | CA$7.29 Million | ▼ -35.6% |
| 2011 | -3.47x | CA$-22.54 Million | CA$6.50 Million | ▲ +51.9% |
| 2010 | -7.21x | CA$-18.03 Million | CA$2.50 Million | ▼ -89.8% |
| 2009 | -3.80x | CA$-16.82 Million | CA$4.43 Million | ▼ -12.7% |
| 2008 | -3.37x | CA$-15.29 Million | CA$4.53 Million | ▲ +29.9% |
| 2007 | -4.81x | CA$-13.57 Million | CA$2.82 Million | ▼ -9.5% |
| 2006 | -4.39x | CA$-12.16 Million | CA$2.77 Million | ▲ +26.8% |
| 2005 | -6.00x | CA$-11.05 Million | CA$1.84 Million | ▲ +28.5% |
| 2004 | -8.39x | CA$-9.22 Million | CA$1.10 Million | ▼ -58.6% |
| 2003 | -5.29x | CA$-5.48 Million | CA$1.03 Million | ▼ -2.9% |
| 2002 | -5.15x | CA$-7.26 Million | CA$1.41 Million | ▼ -275.5% |
| 2001 | -1.37x | CA$-4.27 Million | CA$3.12 Million | ▲ +24.4% |
| 2000 | -1.81x | CA$-3.16 Million | CA$1.74 Million | ▲ +19.9% |
| 1999 | -2.26x | CA$-534.35K | CA$236.10K | — |